S-Network Medical Breakthroughs Index

An index of small and mid-cap biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.

As June 7, 2023 Index Level 3-Month 6-Month 1-Year YTD
Price Return 7,424.2 11.3% 11.3% 22.7% 8.5%
Total Return
Net Total Return
Index Level 7,424.2
3-Month 11.3%
6-Month 11.3%
1-Year 22.7%
YTD 8.5%
Index Level
3-Month
6-Month
1-Year
YTD
Index Level
3-Month
6-Month
1-Year
YTD

As of June 7, 2023

Characteristics

Index Symbol (Price Return) PMBI
Index Symbol (Total Return) NA
Index Symbol (Net Total Return) PMBINT
Number of Constituents 113
Market Capitalization $177 Billion
Adjusted Market Capitalization $116 Million
Rebalancings Quarterly
Dividend Yield 0.0%

Composition

Top Index Constituents
As of June 8, 2023

Interested in Market Data packages?

VettaFi's indexes are widely used by financial firms, industry stakeholders and professionals to support a variety of business functions. We offers a range of end-of-day and historical index data subscriptions.

Contact Us